Key facts
- Notable investors include Guoyao Venture Capital, Binhu State-owned Capital Operation Holding Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kunlong Kangxin
- ·The full record, as it builds
Funding rounds
No funding rounds for Kunlong Kangxin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kunlong Kangxin
Developer of high-end intelligent cardiac medical devices designed for heart disease diagnosis. The company focuses on the research and development and industrialization of digital analysis intelligent equipment and a full set of analysis tools that integrates equipment production, software development, and algorithm research, enabling clients with complete digital analysis of cardiac function indicators and intelligent diagnosis solutions for heart diseases.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2021
- Website
- ahklkx.com/
- Ownership
- Privately Held (backing)
Kunlong Kangxin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kunlong Kangxin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kunlong Kangxin in its N-PORT filings yet. We sweep new filings monthly.